CR7117A - METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM PHARMACO - Google Patents
METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM PHARMACOInfo
- Publication number
- CR7117A CR7117A CR7117A CR7117A CR7117A CR 7117 A CR7117 A CR 7117A CR 7117 A CR7117 A CR 7117A CR 7117 A CR7117 A CR 7117A CR 7117 A CR7117 A CR 7117A
- Authority
- CR
- Costa Rica
- Prior art keywords
- manufacturing
- pharmaceutical composition
- uniform
- pharmaco
- distribution
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000012239 silicon dioxide Nutrition 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 238000009827 uniform distribution Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describe un metodo para fabricar una composicion farmaceutica que tiene una distribucion y potencia del farmaco uniformes, el cual utiliza dioxido de silicio para reducir la perdida de ingrediente activo durante el proceso de fabricacion. El metodo es particularmente util para la fabricacion de composiciones para comprimidos de baja dosificacion.A method for manufacturing a pharmaceutical composition having a uniform distribution and potency of the drug is described, which uses silicon dioxide to reduce the loss of active ingredient during the manufacturing process. The method is particularly useful for the manufacture of compositions for low dosage tablets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR7117A CR7117A (en) | 2003-10-21 | 2003-10-21 | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM PHARMACO |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CR7117A CR7117A (en) | 2003-10-21 | 2003-10-21 | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM PHARMACO |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR7117A true CR7117A (en) | 2004-02-02 |
Family
ID=44839131
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR7117A CR7117A (en) | 2003-10-21 | 2003-10-21 | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM PHARMACO |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR7117A (en) |
-
2003
- 2003-10-21 CR CR7117A patent/CR7117A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR033288A1 (en) | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM PHARMACO | |
| ECSP055528A (en) | PHARMACEUTICAL COMPOSITION THAT HAS A UNIFORM DISTRIBUTION AND POWER OF FARMACO | |
| PE20030823A1 (en) | DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS AN ACTIVE INGREDIENT | |
| CL2011000170A1 (en) | Solid and stabilized pharmaceutical composition comprising a pharmaceutically active ingredient, titanium oxide and a plasticizer; procedure to stabilize the pharmaceutical composition during a light irradiation. | |
| ES2191977T3 (en) | SOLUTIONS AND DISPERSIONS IN SOLID STATE OF PHARMACOS LITTLE SOLUBLES IN WATER. | |
| GT199900203A (en) | CELECOXIB COMPOSITIONS. | |
| NO20062504L (en) | Compositions and dosage forms for improved absorption | |
| CY1115526T1 (en) | PHARMACEUTICAL COMPOSITION WHICH INCLUDES PIMOBENDANI | |
| PE20150773A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF PHENYLEPHRINE | |
| PA8579801A1 (en) | PHARMACEUTICAL COMPOSITIONS OF SEMIORDENED AND POLYMER DRUGS | |
| EA201100430A1 (en) | STABLE COMBINED PHARMACEUTICAL COMPOSITION | |
| DK1746980T3 (en) | Pharmaceutical dosage form comprising pellets as well as their manufacturing process | |
| UA96622C2 (en) | Solid dosage forms comprising aliskiren obtained by solvent-free granulation process | |
| AR095159A2 (en) | A PHARMACEUTICAL COMPOSITION IN THE FORM OF A CAPSULE FOR ORAL ADMINISTRATION | |
| AR062925A1 (en) | METHOD FOR MANUFACTURING TABLETS CONTAINING PHARMACOLOGICALLY ACTIVE AGENTS | |
| MXPA06011467A (en) | Active substance combination comprising a carbinol combined to at least an nsaid. | |
| MXPA05008403A (en) | Use of edible acid in fast-dispersing pharmaceutical solid dosage forms. | |
| AR026010A1 (en) | ORAL DOSING UNIT ORALALLY DISARNING CONTAINING THE MIRTAZAPINE ANTIDEPRESSIVE AS ACTIVE INGREDIENT | |
| CR7117A (en) | METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM PHARMACO | |
| SE0000303D0 (en) | Novel compounds | |
| RU2008115908A (en) | PHARMACEUTICAL COMPOSITION CONTAINING HYALURONIDASE AND LIPOSOMES FOR EXTERNAL USE | |
| AR076907A1 (en) | COMPOSITIONS WITH FAST RELEASE OF FARMACO | |
| AR048970A1 (en) | SOLID PHARMACEUTICAL FORMULATION | |
| DOP2003000655A (en) | PHARMACEUTICAL COMPOSITION THAT HAS A DISTRIBUTION AND UNIFORM POWER OF FARMACO | |
| BRPI0507985A (en) | piperazine urea derivatives for the treatment of endometriosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |